| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
2 companies
Somaiya Mayur Ian is a Chief Financial Officer at NewAmsterdam Pharma Co N.V. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $3.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | NAMSW Newamsterdam Pharma Co N.V. | Chief Financial Officer | Sale+OE | 100,000 | $32.61 | $3,260,617.98 | -20.2% | - | - | |
| Jan 5, 2026 | NAMS Newamsterdam Pharma Co N.V. | Chief Financial Officer | Sell | 5,118 | $33.25 | $170,173.50 | -13.5% | +1.9% | - | |
| Jan 28, 2025 | NAMS Newamsterdam Pharma Co N.V. | Chief Financial Officer | Sale+OE | 61,883 | $0.00 | - | -26.8% | -16.9% | +48.6% |